Tandem Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
4,294
-435
-9% -$101K 0.84% 31
2026
Q1
$1.16M Sell
4,729
-670
-12% -$156K 0.98% 28
2025
Q4
$1.12M Sell
5,399
-838
-13% -$166K 0.94% 29
2025
Q3
$1.16M Sell
6,237
-120
-2% -$20.6K 0.95% 30
2025
Q2
$971K Buy
6,357
+707
+13% +$109K 0.85% 31
2025
Q1
$937K Sell
5,650
-19
-0.3% -$2.97K 0.93% 28
2024
Q4
$820K Buy
+5,669
New +$878K 0.78% 28

Other funds holding JNJ

Tandem Investment Partners's JNJ Position: Q2 2026 in Review

Tandem Investment Partners reduced its Johnson & Johnson (JNJ) stake by 9.2% in Q2 2026, selling an estimated $101K and leaving 4,294 shares worth $1.09M. The position accounts for 0.84% of the portfolio, ranked #31.

Tandem Investment Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.16M in Q3 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tandem Investment Partners held 4,294 shares of Johnson & Johnson worth $1.09M as of Q2 2026.
  • Tandem Investment Partners sold 435 Johnson & Johnson shares in Q2 2026, an estimated $101K.
  • Johnson & Johnson made up 0.84% of Tandem Investment Partners's portfolio in Q2 2026, its #31 holding.
  • Tandem Investment Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Tandem Investment Partners's Johnson & Johnson position peaked at $1.16M in Q3 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tandem Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.